
CureVac N.V.
CVAC • Biotechnology
$4.66
— 0.00 (0.00%)
Current price
EarningsLatest report: Nov 24, 2025
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$1.05B
Growth
78.7%
Cash Flow
2/5
Trend
Volatile
Evidence
Stable or improving margins · 30.3%Positive revenue growth · 59.4%Positive free cash flow · 0.37Reasonable earnings multiple · 4.56Manageable debt level · 0.06
Financial data as of: Nov 24, 2025, 12:00 AM UTCLast earnings update: Nov 24, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.66
Change0.00%
Shares Out225.17M
Market Cap$1.05B
52W Range2.48 - 5.72
Beta1.84
P/E0.95
P/S19.10
P/B1.19
P/FCF35.01
EV/Sales12.06
EV/EBITDA2.05
Price$4.66
Change0.00%
Shares Out225.17M
Market Cap$1.05B
52W Range2.48 - 5.72
Beta1.84
P/E0.95
P/S19.10
P/B1.19
P/FCF35.01
EV/Sales12.06
EV/EBITDA2.05
EV/FCF22.11
Earnings Yield105.69%
FCF Yield2.86%
Dividend Yield0.00%
Gross Margin80.23%
Oper. Margin33.20%
Profit Margin30.30%
Debt/Eq0.06
Current Ratio7.28
Quick Ratio7.27
Revenue 5Y78.74%
Target$21.00
Target Upside350.64%
Target Median$21.00
Target Range5.00 - 37.00
Volume728.78K
Avg Volume1.17M
EPS Surprise0.07
Investment DNA
How strong this company looks for long-term investors
75
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
94/100
Why this score▼
Stable or improving margins · 30.3%Positive revenue growth · 59.4%Positive free cash flow · 0.37Reasonable earnings multiple · 4.56Manageable debt level · 0.06Healthy liquidity · 7.28
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
56/100
Neutral
Bullish
2
Hold
5
Bearish
1
Price Target
2026-06-06
Low
$5.00
Mean
$21.00
Median
$21.00
High
$37.00
🧾
No insider activity
No recent insider transactions available.
